The industry’s first fully automated cell culture instrument with data-driven quality management

SINFONIA TECHNOLOGY CO., LTD. (Head office: Minato-ku, Tokyo; President: Fuminori Saito) has been developing a fully automated cell culture instrument in collaboration with the Foundation for Biomedical Research and Innovation at Kobe (FBRI; Locations: Kobe City, Hyogo Prefect.; President: Tasuku Honjo, M.D.,Ph.D.). With the successful results of demonstration experiments with human iPS cells and mesenchymal [...]

Celtarys Research closes a first investment round of 650,000 euros

The start up Celtarys Research, born at the University of Santiago de Compostela and dedicated to the development of fluorescent tools for drug discovery, has closed a seed capital investment round of 650,000 euros. In the round have participated the Galician institutional funds of the Xunta de Galicia - through XesGalicia - and VigoActivo, as [...]

Rapiscan® Systems and Metrohm Team Up to Provide Raman Spectrometers to the Security Market

Riverview -- Rapiscan Systems Inc., (“Rapiscan”) a subsidiary of OSI Systems, Inc., and Metrohm USA (“Metrohm”) announced today that they have entered into an agreement to have Rapiscan distribute Metrohm handheld Raman spectrometer products globally through Rapiscan’s Instruments Business Unit. The MIRA and the TacticID® products use Raman spectroscopy technology to determine the chemical composition [...]

NanoCellect Biomedical Expands its Global Distribution Network to Middle Eastern and Africa

DUBAI – NanoCellect Biomedical Inc. a privately-held life sciences company, focused on developing microfluidic based cell analysis and sorting solutions, has signed an agreement appointing Alliance Global (AGBL Group) as the exclusive distributor in the Middle East, Africa, Levant, Turkey, Pakistan, Bangladesh and Sri Lanka. Dr. Will Alaynick, Co-founder and Vice President International at NanoCellect [...]

Dr. Mikael Dolsten Named to Agilent Board of Directors

Pfizer executive brings strong scientific and medical expertise to Agilent board SANTA CLARA, Calif. --  Agilent Technologies, Inc. (NYSE: A) today announced that Dr. Mikael Dolsten, chief scientific officer and president, Worldwide Research, Development and Medical, Pfizer Inc. has been elected to Agilent’s board of directors, effective Sept. 21, 2021. Dr. Dolsten brings 30 years [...]

Phenomenex Announces the Release of New Biozen® SEC Size Exclusion Chromatography Columns

TORRANCE, Calif. -- Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announces the successful launch of NEW Biozen® SEC Size Exclusion Chromatography Columns to the existing Biozen portfolio of biological workflow products for the analysis of monoclonal antibodies, biosimilars and other biomolecules. Size exclusion chromatography, or SEC, is a technique [...]

Aptamers for Targeting SARS-CoV-2 Proteins

AMSBIO has further expanded its product range to help in the fight against COVID-19 with the introduction of a new range of aptamers targeting SARS-CoV-2 proteins to aid development of new kits and assays.Aptamers are small single-stranded RNA or DNA oligonucleotides that fold in a three-dimensional conformation allowing them to bind specifically to a target. [...]

U.S. Dept. of Health and Human Services Taps Draper to Develop Lung-on-a-Chip Technology to Study SARS-CoV-2

CAMBRIDGE, MA—Draper has received a $719,000 federal contract from the U.S. Department of Health and Human Services (HHS) to enhance the company’s tissue-chip platform for advanced studies of viral infection. With the contract, Draper will design a model for human airway tissue and adapt its PREDICT96 platform to collect data for SARS-CoV-2 infection studies. The [...]

Opentrons Announces $200 Million Series C Round Led by Softbank

NEW YORK, NY: Today Opentrons Labworks Inc. has announced SoftBank Vision Fund 2* has led the company’s $200 million Series C investment with participation by Khosla Ventures. Opentrons will use this fundraising round to further invest in its automated lab platform globally. “Biology opens the door to solve many of humanity’s grand challenges. For far [...]

Oxford Nanopore broadens its Q20+ Early Access Programme and releases new nanopore, R10.4, into this early access programme

The Oxford Nanopore “Q20+” kit is now available to any Oxford Nanopore user who registers their interest. As part of this Early Access programme, Oxford Nanopore will make available its latest flow cell chemistry, “R10.4” for first user trials. First announced at the London Calling conference in May 2021, the Q20+ chemistry enables users to generate [...]

Access IBO on Knowledge Center